Feb. 25, 2025 – The FDA has approved a new treatment plan for a long-acting injection, making it easier for people with moderate to severe opioid use disorder (OUD) to start and keep up with ...

DEA and HHS have delayed implementation of two rules for telehealth prescribing of buprenorphine until the end of the year to ...

What you need to know about opioid overdose reversal drug nalmefene’s risks, effectiveness and clinical concerns ...

Opioid addiction often starts where many don’t expect it — in the recovery room after surgery. Too often, patients are prescribed more pain medication than they actually need, leading to ...

Academic cites challenges of addiction after Monash University finds many injured workers receiving 'high-risk' prescriptions ...